Genomic drivers leading to glioblastoma metastasis are not fully understood, but mutations in TP53, IGFBP2, BRACA1, ARID1A, SMARCB1 and matrix metalloproteinase have been associated with tumor progression and dissemination. This evidence concerns the gene TP53 and glioblastoma.